Aeras, Oxford Uni, Okairos club $2.9 mn on TB, HIV, Malaria vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a bioph...Read more

BioDiem expands antimicrobial profile

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agre...Read more

NIH develops groundbreaking dengue vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jan, 2013

Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has ...Read more

GSK's malaria vaccine might be reality in two years

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: The results of the phase III clinical trials of a malaria vaccine being developed by British pharmaceutical m...Read more

Sanofi working to bring dengue under control

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press confere...Read more

CSL Biotherapies awarded Pandemic Preparedness Contract by US Government

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply...Read more

Serum Institute acquires Dutch biologics company

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine co...Read more

Mitsubishi to acquire Medicago at $1.16 per share

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...Read more

H7N9 claims more lives in China

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2014

Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new h...Read more

Vaccines do not cause autism: Study

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childho...Read more

EU join hands to develop personalized cancer vaccines

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to creat...Read more

Focus on needs of society: Dr Weidong Yin

Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of t...Read more

Panacea gets govt order worth $34 million

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order ...Read more

Emergent to market VaxInnate flu vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusi...Read more

WHO: Bird flu is back in China

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family...Read more

FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-cultur...Read more

Takeda acquires LigoCyte Pharmaceuticals at $60 mn

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...Read more

FDA approves GSK's combo meingitis vaccine

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2012

Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Gr...Read more